LL-37-infused HA/SF hydrogel scaffold promotes gingival regeneration, boosting angiogenesis and anti-inflammatory effects in rats.
Background
Gingival recession is a prevalent oral health issue, exposing tooth roots, causing dentin hypersensitivity, and accelerating periodontitis progression. Current gold-standard treatments, such as autogenous palatal grafts, necessitate a second surgical site, increasing patient discomfort and morbidity. This creates a critical need for alternative biomaterials that can effectively augment gingival soft tissue without these drawbacks. The antimicrobial peptide LL-37 is being investigated for its broad-spectrum antibacterial, immunomodulatory, and regenerative properties, making it a promising candidate for tissue engineering applications, particularly in complex oral environments.
Study Design
Researchers developed a multifunctional hyaluronic acid/silk fibroin (HA/SF) hydrogel scaffold, further enhanced by incorporating epigallocatechin gallate (EGCG) and the antimicrobial peptide LL-37. This HA/SF/EGCG/LL37 scaffold was designed to mimic the native extracellular matrix (ECM) and allow for minimally invasive delivery. In vitro, the scaffold's antibacterial activity was assessed by inhibiting bacterial growth and adhesion. Its anti-inflammatory effects were evaluated by measuring pro-inflammatory cytokine expression in LPS-stimulated macrophages. For in vivo assessment, the scaffold was applied in an animal model using rats, comparing its regenerative capabilities against control groups.
Results
The novel HA/SF/EGCG/LL37 hydrogel demonstrated a multifaceted therapeutic profile. In vitro, it effectively inhibited bacterial growth and adhesion, and significantly reduced pro-inflammatory cytokine expression in LPS-stimulated macrophages. This suggests a direct anti-inflammatory and antimicrobial action at the cellular level. In the rat model, the scaffold exhibited superior regenerative outcomes compared to controls. It significantly increased neovascular density, indicating enhanced blood vessel formation crucial for tissue repair. Furthermore, the scaffold improved collagen fiber organization, a key structural component of healthy gingival tissue. The study also observed enhanced anti-inflammatory and antioxidant effects in vivo. These combined actions suggest a robust biological response.
The
HA/SF/EGCG/LL37scaffold significantly increased neovascular density, improved collagen fiber organization, and enhanced anti-inflammatory and antioxidant effects versus controls in rats.
Key Findings
- HA/SF/EGCG/LL37 hydrogel inhibited bacterial growth and adhesion in vitro.
- The hydrogel significantly reduced pro-inflammatory cytokine expression in
LPS-stimulated macrophages. - In rats, the scaffold significantly increased neovascular density.
- The scaffold improved collagen fiber organization in regenerated gingival tissue.
- Enhanced anti-inflammatory and antioxidant effects were observed in vivo with the scaffold.
Why It Matters
This research introduces a promising, biologically active strategy for gingival soft tissue regeneration that could revolutionize treatment for gingival recession and periodontitis. The HA/SF/EGCG/LL37 hydrogel offers a minimally invasive, single-site alternative to traditional autografts, potentially reducing patient discomfort and recovery time. For peptide users and clinicians, this highlights LL-37's potential beyond its antimicrobial role, showcasing its regenerative and immunomodulatory capabilities in a practical delivery system. While preclinical, this work lays the groundwork for developing a usable protocol, suggesting future clinical trials could explore its efficacy in human subjects, potentially integrating into existing periodontal treatment paradigms to balance oral microbiota, dampen inflammation, and reduce oxidative stress.
ll-37
gingival-regeneration
periodontitis
hydrogel
antimicrobial
anti-inflammatory